The open-market sales by the CEO and a director are notable but not extreme; however, the concentration of tax-withholding events across the executive team suggests a recent vesting of equity awards rather than negative sentiment. Traders should monitor for follow-on filings and upcoming earnings for signals of underlying confidence.
Price Chart
Executive Summary
Kiniksa Pharmaceuticals insiders executed a cluster of transactions over a 7-day window, including option exercises and open-market sales. CEO Sanj Patel and Director Barry Quart sold $364K and $345K in shares respectively, while other C-suite executives surrendered shares for tax withholding after exercising options, generating no cash proceeds.
Key Financial Metrics
Key Facts
- CEO Sanj Patel sold 7,278 shares for $363,973 in an open-market transaction on 2026-04-06.
- Director Barry Quart sold 6,900 shares for $345,000 on 2026-04-06.
- Multiple C-suite executives exercised stock options and surrendered shares to cover taxes, including CFO Ragosa ($63,769), CSO Tessari ($41,403), CMO Paolini ($59,120), COO Moat ($37,880), and CAO Megna ($81,534).
- All option exercises were at $0 or nominal strike prices, consistent with vesting of equity awards.
- Total open-market sales amounted to $709K; total tax-related dispositions totaled $483K.
Financial Impact
Total insider selling (open market + tax withholding) = $1.19M, representing 0.03% of $3.7B market cap.
Risk Factors
- Concentrated insider selling, especially by the CEO, could signal reduced conviction in near-term prospects.
- Perception of insider selling may pressure sentiment, even if driven by tax planning.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-KNSA-1775680812913 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $76.00 | awaiting T+60 | — | $86.68 (+14.07%) |
Oct 27, 2026 today | Press Release | $75.00 | awaiting T+60 | — | $86.68 (+15.58%) |
Oct 22, 2026 4d ago | 8-K | $76.73 | awaiting T+60 | — | $86.68 (+12.97%) |
Oct 22, 2026 4d ago | Press Release | $80.79 | awaiting T+60 | — | $86.68 (+7.30%) |
Sep 3, 2026 7w ago | 144 | $77.91 | awaiting T+60 | — | $86.68 (+11.26%) |
Jul 28, 2026 13w ago | 8-K | $79.44 $79.70 | ▲ +0.33% | ▼ −4.02% | $86.68 (+9.12%) |
Jul 28, 2026 13w ago | Press Release | $79.44 $79.70 | ▲ +0.33% | ▼ −4.02% | $86.68 (+9.12%) |
May 26, 2026 21w ago | 8-K | $51.84 $78.47 | ▲ +51.37% | ▲ +49.49% | $86.68 (+67.22%) |
May 1, 2026 25w ago | 8-K | $57.62 $80.92 | ▲ +40.44% | ▲ +38.58% | $86.68 (+50.44%) |
Apr 28, 2026 25w ago | 144 | $52.99 $62.84 | ▼ −18.59% | ▼ −14.48% | $86.68 (−63.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers